BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1587 related articles for article (PubMed ID: 8613473)

  • 21. Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.
    Saitoh S; Kurisaka M; Mori K; Maeda N; Fujimoto S
    Jpn J Cancer Res; 1997 Mar; 88(3):289-95. PubMed ID: 9140114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newer approaches to regional cancer therapy through tumour immunology: is there a 'breakthrough'?
    Stephens FO
    Aust N Z J Surg; 1997 Jan; 67(1):2-4. PubMed ID: 9033367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the co-stimulatory molecule CD40 on melanoma cells.
    Thomas WD; Smith MJ; Si Z; Hersey P
    Int J Cancer; 1996 Dec; 68(6):795-801. PubMed ID: 8980186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line.
    Pomp J; Ouwerkerk IJ; Hermans J; Wondergem J; Cornelisse CJ; Leer JW; Schrier PI
    Radiat Res; 1996 Oct; 146(4):374-81. PubMed ID: 8927709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of nuclear matrix proteins: method and potential applications.
    Dynlacht JR; Henthorn J; O'Nan C; Dunn ST; Story MD
    Cytometry; 1996 Aug; 24(4):348-59. PubMed ID: 8866219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional regulation of the alpha 4 integrin subunit gene in the metastatic spread of uveal melanoma.
    Larouche N; Larouche K; Béliveau A; Leclerc S; Salesse C; Pelletier G; Guérin SL
    Anticancer Res; 1998; 18(5A):3539-47. PubMed ID: 9858937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PTEN tumour suppressor gene and malignant melanoma.
    Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
    Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant melanoma of the nictitating membrane in a cat (Felis vulgaris).
    Roels S; Ducatelle R
    J Comp Pathol; 1998 Aug; 119(2):189-93. PubMed ID: 9749364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions.
    Geertsen RC; Hofbauer GF; Yue FY; Manolio S; Burg G; Dummer R
    J Invest Dermatol; 1998 Sep; 111(3):497-502. PubMed ID: 9740247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents.
    Onishi Y; Yamaura T; Tauchi K; Sakamoto T; Tsukada K; Nunome S; Komatsu Y; Saiki I
    Biol Pharm Bull; 1998 Jul; 21(7):761-5. PubMed ID: 9703264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2A.
    Martinetti A; Seregni E; Belli F; Mazzocchi A; Agresti R; Cascinelli N; Greco M; Bombardieri E
    Anticancer Res; 1998; 18(3B):2027-30. PubMed ID: 9677461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.
    Mordoh J; Kairiyama C; Bover L; Solarolo E
    Medicina (B Aires); 1997; 57(4):421-7. PubMed ID: 9674264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of cutaneous depigmentation in Mexican patients with malignant melanoma.
    Rodríguez-Cuevas S; López-Chavira A; Zepeda del Río G; Cuadra-García I; Fernández-Diez J
    Arch Med Res; 1998; 29(2):155-8. PubMed ID: 9650331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitrochlear lymph nodes as a site of melanoma metastasis.
    Hunt JA; Thompson JF; Uren RF; Howman-Giles R; Harman CR
    Ann Surg Oncol; 1998; 5(3):248-52. PubMed ID: 9607627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
    Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
    Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of 5' region of human tenascin-R gene and characterization of its promoter.
    Gherzi R; Leprini A; Siri A; Zardi L
    DNA Cell Biol; 1998 Mar; 17(3):275-82. PubMed ID: 9539107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of preoperative ultrasonography for patients with dense cataract: a retrospective study of 509 cases.
    Anteby II; Blumenthal EZ; Zamir E; Waindim P
    Ophthalmic Surg Lasers; 1998 Feb; 29(2):114-8. PubMed ID: 9507254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An in vitro study on radiation-induced TNF gene therapy of cancer].
    Cao X; Zhang W; Wang J
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):161-4. PubMed ID: 9387244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfection of IL-2 augments CTL response to human melanoma cells in vitro: immunological characterization of a melanoma vaccine.
    van Elsas A; Aarnoudse C; van der Minne CE; van der Spek CW; Brouwenstijn N; Osanto S; Schrier PI
    J Immunother; 1997 Sep; 20(5):343-53. PubMed ID: 9336741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine needle aspiration biopsy of metastatic malignant melanoma with "rhabdoid" features. Frequency, cytologic features, pitfalls and ancillary studies.
    Slagel DD; Raab SS; Silverman JF
    Acta Cytol; 1997; 41(5):1426-30. PubMed ID: 9334131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.